Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.

Russell-Goldman E, Hornick JL, Qian X, Jo VY.

Cancer Cytopathol. 2018 Nov;126(11):942-949. doi: 10.1002/cncy.22056. Epub 2018 Oct 30.

PMID:
30376220
2.

Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.

Hung YP, Fletcher CD, Hornick JL.

Mod Pathol. 2016 Apr;29(4):370-80. doi: 10.1038/modpathol.2016.31. Epub 2016 Feb 5.

3.

Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.

Machado I, Yoshida A, Morales MGN, Abrahão-Machado LF, Navarro S, Cruz J, Lavernia J, Parafioriti A, Picci P, Llombart-Bosch A.

Ann Diagn Pathol. 2018 Jun;34:1-12. doi: 10.1016/j.anndiagpath.2017.11.011. Epub 2017 Nov 29.

PMID:
29661713
4.

Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.

McCuiston A, Bishop JA.

Head Neck Pathol. 2018 Mar;12(1):89-94. doi: 10.1007/s12105-017-0830-1. Epub 2017 Jun 14.

5.

The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.

Shibuya R, Matsuyama A, Nakamoto M, Shiba E, Kasai T, Hisaoka M.

Virchows Arch. 2014 Nov;465(5):599-605. doi: 10.1007/s00428-014-1627-1. Epub 2014 Jul 17.

PMID:
25031013
6.

NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.

Yoshida A, Sekine S, Tsuta K, Fukayama M, Furuta K, Tsuda H.

Am J Surg Pathol. 2012 Jul;36(7):993-9. doi: 10.1097/PAS.0b013e31824ee43c.

PMID:
22446943
7.

ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions.

Le Guellec S, Velasco V, Pérot G, Watson S, Tirode F, Coindre JM.

Mod Pathol. 2016 Dec;29(12):1523-1531. doi: 10.1038/modpathol.2016.155. Epub 2016 Aug 26.

8.

Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors.

Halliday BE, Slagel DD, Elsheikh TE, Silverman JF.

Diagn Cytopathol. 1998 Dec;19(6):410-6.

PMID:
9839129
10.

Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.

Hung YP, Fletcher CD, Hornick JL.

Mod Pathol. 2016 Nov;29(11):1324-1334. doi: 10.1038/modpathol.2016.140. Epub 2016 Jul 22.

11.

PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.

Toki S, Wakai S, Sekimizu M, Mori T, Ichikawa H, Kawai A, Yoshida A.

Histopathology. 2018 Oct;73(4):645-652. doi: 10.1111/his.13689. Epub 2018 Aug 2.

PMID:
29920735
12.

Transthoracic fine-needle aspiration biopsy of pulmonary spindle cell and mesenchymal lesions: a study of 61 cases.

Hummel P, Cangiarella JF, Cohen JM, Yang G, Waisman J, Chhieng DC.

Cancer. 2001 Jun 25;93(3):187-98.

PMID:
11391606
14.

Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.

Mito JK, Qian X, Doyle LA, Hornick JL, Jo VY.

Am J Clin Pathol. 2017 Aug 1;148(2):179-189. doi: 10.1093/ajcp/aqx060.

PMID:
28898989
15.

Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.

Machado I, Yoshida A, López-Guerrero JA, Nieto MG, Navarro S, Picci P, Llombart-Bosch A.

Pathol Res Pract. 2017 Sep;213(9):1048-1053. doi: 10.1016/j.prp.2017.08.002. Epub 2017 Aug 25.

PMID:
28864350
16.

Fine-needle aspiration of soft tissue perineurioma: A comparative analysis of cytomorphology and immunohistochemistry with benign and malignant mimics.

Yang EJ, Hornick JL, Qian X.

Cancer Cytopathol. 2016 Sep;124(9):651-8. doi: 10.1002/cncy.21725. Epub 2016 May 9.

17.

Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.

Cessna MH, Zhou H, Perkins SL, Tripp SR, Layfield L, Daines C, Coffin CM.

Am J Surg Pathol. 2001 Sep;25(9):1150-7.

PMID:
11688574
18.

PAX immunoreactivity identifies alveolar rhabdomyosarcoma.

Sullivan LM, Atkins KA, LeGallo RD.

Am J Surg Pathol. 2009 May;33(5):775-80. doi: 10.1097/PAS.0b013e318191614f.

PMID:
19145202
19.

PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.

Hung YP, Lee JP, Bellizzi AM, Hornick JL.

Histopathology. 2017 Nov;71(5):786-794. doi: 10.1111/his.13288. Epub 2017 Sep 6.

PMID:
28640941
20.

The Utility of NKX2.2 and TLE1 Immunohistochemistry in the Differentiation of Ewing Sarcoma and Synovial Sarcoma.

Rooper LM, Sharma R, Gocke CD, Belchis DA.

Appl Immunohistochem Mol Morphol. 2017 Aug 9. doi: 10.1097/PAI.0000000000000573. [Epub ahead of print]

PMID:
28800015

Supplemental Content

Support Center